2024-02-16 12:56:48 ET
More on Applied Therapeutics
- Applied Therapeutics: Update Following Failure In Diabetic Cardiomyopathy (Downgrade)
- ARISE-HF Phase 3 Trial Likely To Disappoint Due To Multiple Red Flags
- Applied Therapeutics: Multiple Inflection Points Could Generate Substantial Value
- Applied Therapeutics gains as late-stage trial for lead asset succeeds
- Biggest stock movers today: Palantir, Peloton, Medical Properties Trust, and more
Read the full article on Seeking Alpha
For further details see:
Applied Therapeutics hits 52-week high on trial success